Omega-3 Fatty Acids in Psychiatry
Authors:
- David MischoulonDMDavid Mischoulon
- Marlene P. FreemanMFMarlene P. Freeman
- 1 March 2013
- journal article
- review article
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 36 (1) , 15-23
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-AnalysisJournal of the American Academy of Child & Adolescent Psychiatry, 2011
- Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in DepressionThe Journal of Clinical Psychiatry, 2011
- Omega-3 for Bipolar DisorderThe Journal of Clinical Psychiatry, 2011
- Updated systematic review and meta-analysis of the effects of n−3 long-chain polyunsaturated fatty acids on depressed moodThe American Journal of Clinical Nutrition, 2010
- Omega-3 fatty acids for bipolar disorderCochrane Database of Systematic Reviews, 2008
- A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty AcidsThe Journal of Clinical Psychiatry, 2007
- Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in PsychiatryThe Journal of Clinical Psychiatry, 2006
- Omega-3 Fatty Acids and Mood DisordersAmerican Journal of Psychiatry, 2006